7 Jul 2026Open access
Chitosan/β-cyclodextrin nanocarriers enhance 5-fluorouracil efficacy against colorectal cancer via pH-responsive release and apoptosis modulationPublisher siteScientific Reports, Nanoparticle-Based Drug Delivery
UniversitiesHemat M. Dardeer
Active, last published 2026
In nanoparticle-based drug delivery
Hemat M.
Dardeer
Scholar“Research focused on Nanoparticle-Based Drug Delivery and adjacent fields.”
South Valley University
Claim Your Profile0
H-index
0
Citations
Hemat has not officially claimed their profile. If you are Hemat, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
emat M. Dardeer is a researcher working on Nanoparticle-Based Drug Delivery. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Hemat's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Nanoparticle-Based Drug Delivery×1
04 · Where I am
Affiliations
Affiliation on published researchSouth Valley UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
1 workExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Hemat?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you